000 | 01939 a2200505 4500 | ||
---|---|---|---|
005 | 20250516123147.0 | ||
264 | 0 | _c20130709 | |
008 | 201307s 0 0 eng d | ||
022 | _a1525-2191 | ||
024 | 7 |
_a10.1016/j.ajpath.2012.10.019 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHuber, Sally Ann | |
245 | 0 | 0 |
_aSlam haplotype 2 promotes NKT but suppresses Vγ4+ T-cell activation in coxsackievirus B3 infection leading to increased liver damage but reduced myocarditis. _h[electronic resource] |
260 |
_bThe American journal of pathology _cFeb 2013 |
||
300 |
_a401-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 |
_aAdaptive Immunity _xdrug effects |
650 | 0 | 4 |
_aAlanine Transaminase _xblood |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntigens, CD _xgenetics |
650 | 0 | 4 |
_aCoxsackievirus Infections _xcomplications |
650 | 0 | 4 |
_aEnterovirus B, Human _xdrug effects |
650 | 0 | 4 |
_aGalactosylceramides _xpharmacology |
650 | 0 | 4 |
_aHaplotypes _xgenetics |
650 | 0 | 4 |
_aHepatitis _xcomplications |
650 | 0 | 4 |
_aLiver _ximmunology |
650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
650 | 0 | 4 | _aLymphocyte Count |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aMyocarditis _xblood |
650 | 0 | 4 |
_aNatural Killer T-Cells _xdrug effects |
650 | 0 | 4 | _aPolymorphism, Genetic |
650 | 0 | 4 |
_aReceptors, Antigen, T-Cell, gamma-delta _ximmunology |
650 | 0 | 4 |
_aReceptors, Cell Surface _xgenetics |
650 | 0 | 4 | _aSignaling Lymphocytic Activation Molecule Family Member 1 |
650 | 0 | 4 |
_aTroponin I _xblood |
650 | 0 | 4 |
_aViral Load _ximmunology |
700 | 1 | _aRoberts, Brian | |
700 | 1 | _aMoussawi, Mohamad | |
700 | 1 | _aBoyson, Jonathan E | |
773 | 0 |
_tThe American journal of pathology _gvol. 182 _gno. 2 _gp. 401-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ajpath.2012.10.019 _zAvailable from publisher's website |
999 |
_c22303959 _d22303959 |